EyePoint (EYPT) Non-Current Deferred Tax Liability (2011)

EyePoint (EYPT) posted Non-Current Deferred Tax Liability of $13000.0 for Q2 2011.

EyePoint (EYPT) Non-Current Deferred Tax Liability (2011) Analysis & Trends

EyePoint has reported Non-Current Deferred Tax Liability for 1 years, with the latest figure at $13000.0 in Q2 2011.

Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $13000.0 in Q2 2011, while the trailing twelve-month figure through Jun 2011 was $13000.0 (changed N/A YoY) and the FY2011 annual result came in at $13000.0, changed N/A from the prior year.
Non-Current Deferred Tax Liability held at $13000.0 in Q2 2011 per EYPT's latest filing.
Over five years, Non-Current Deferred Tax Liability peaked at $13000.0 in Q2 2011 and troughed at $13000.0 in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	EyePoint	1.25 Bn	1.07 Bn	507,000.00

Download Data

Date	Value
Jun 30, 2011	13,000.00
Jun 30, 2011	13,000.00